Article
Novel hematological parameters for the evaluation of patients with myeloproliferative neoplasms: the immature platelet and reticulocyte fractions.
Annals of hematology - 1 May 2017
Strati Paolo, Bose Prithviraj, Lyle Lindsey, Gaw Katie, Zhou Lingsha, Pierce Sherry A, Huynh-Lu Julie, Hirsch-Ginsberg Cheryl F, Bueso-Mendoza Daniel E, Bueso-Ramos Carlos E, Verstovsek Srdan
Abstract excerpt
New automated hematology analyzers have led to the availability of novel hematological parameters, including the immature platelet fraction (IPF) and the immature reticulocyte fraction (IRF), both of potential interest in patients with myeloproliferative neoplasms (MPNs). We performed a prospective analysis of 217 patients with MPN, including 32 (15%) with essential thrombocythemia (ET), 43 (20%) with...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
